India ECM round-up: Syngene, Suzlon Energy, Religare, L&T

Rechitan Sorin - Fotolia

Investors could not get enough of India’s Syngene International as a more than 32x covered book helped propel the biotech firm to price its Rp5.5bn ($86m) IPO at the top of its indicative price range.